Cargando…
The Dysregulation and Prognostic Analysis of STRIPAK Complex Across Cancers
The striatin-interacting phosphatase and kinase (STRIPAK) is the highly conserved complex, which gains increased attention in physiology and pathology process recently. However, limited studies reported the details of STRIPAK complex in cancers while some results strongly suggested it plays a vital...
Autores principales: | Xie, Ruiling, Wen, Feng, Qin, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365848/ https://www.ncbi.nlm.nih.gov/pubmed/32754603 http://dx.doi.org/10.3389/fcell.2020.00625 |
Ejemplares similares
-
The STRIPAK Complex Regulates Response to Chemotherapy Through p21 and p27
por: Rodriguez-Cupello, Carmen, et al.
Publicado: (2020) -
STK25 suppresses Hippo signaling by regulating SAV1-STRIPAK antagonism
por: Bae, Sung Jun, et al.
Publicado: (2020) -
SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK
por: Bae, Sung Jun, et al.
Publicado: (2017) -
Cell Cycle Dysregulation and Renal Fibrosis
por: Wu, Yun-Shan, et al.
Publicado: (2021) -
tRNA Function and Dysregulation in Cancer
por: Gupta, Tania, et al.
Publicado: (2022)